The Preventing Illegal Laboratories and Protecting Public Health Act of 2025 aims to enhance the safety and oversight of highly pathogenic agents, which pose significant health risks. This legislation establishes strict logbook requirements for distributors of these agents, ensuring accountability and traceability in their handling and transfer. Under the new law, distributors must maintain a detailed electronic logbook documenting all sales, leases, loans, and transfers of highly pathogenic agents.